ERBB2 and cancer: This categorization has great significance in guiding cancer treatment: hormone receptor-positive patients can benefit from endocrine therapy, while targeted therapy has been extensively utilized in human epidermal growth factor receptor-2-overexpressing (HER2+) patients.